Article ID Journal Published Year Pages File Type
5951365 Atherosclerosis 2010 6 Pages PDF
Abstract
Only a small proportion of patients with heFH reaches the LDL-c treatment target of <2.5 mmol/l. These results emphasize the need for better monitoring, better utilization of available medication and for new treatment options in heFH to further decrease LDL-c levels.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , ,